18:56:01 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



V:NGEN - Nervgen Pharma Corp. - https://www.nervgen.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NGEN - V  0.23.69·3.770.13.75-0.05-1.3199.27114193.78  3.82  3.567.05  2.0515:59:59Jul 1715 min RT 2¢
TSX-V - V0.23.69·3.770.13.75-0.05-1.3130.04652473.78  3.82  3.567.05  2.0515:59:5915 min
NEO ATS - U 3.64-0.16-4.24.415213.76  3.82  3.6215:00:5015 min
Alpha - A 3.74-0.06-1.628.7104233.74  3.77  3.5713:58:4115 min
Omega - O 3.75-0.05-1.32.4933.70  3.75  3.7010:38:4915 min
Pure - P 3.800.0401    Jun 2715 min
Chi-X - X 3.68-0.12-3.21.8693.71  3.73  3.5714:55:4815 min
CX2 - H 3.62-0.18-4.710.639103.72  3.72  3.6213:33:4115 min
CXD - D 3.675-0.125-3.31.86273.71  3.73  3.5715:25:1515 min
TriAct - M 3.808.22758    Sep 04/2015 min
Lynx - Y 3.73-0.07-1.811.341203.77  3.82  3.5713:58:4115 min

Recent Trades - Last 10 of 419
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59V3.75-0.051007 TD Sec79 CIBCK
15:59:54M3.76-0.041001 Anonymous79 CIBC
15:58:39V3.71-0.091001 Anonymous80 National BankK
15:58:39V3.75-0.0510080 National Bank1 AnonymousK
15:58:38V3.75-0.0510080 National Bank1 AnonymousK
15:58:38V3.75-0.0510080 National Bank1 AnonymousK
15:58:38V3.75-0.0510080 National Bank1 AnonymousK
15:58:37V3.75-0.0510080 National Bank1 AnonymousK
15:58:37V3.75-0.0510080 National Bank1 AnonymousK
15:58:36V3.75-0.0510080 National Bank1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-07-17 17:02C:NGEN3.80News ReleaseNervgen president, CEO, director Kelly resigns
2025-07-08 03:47C:NGEN3.50News ReleaseNervgen sells 385,200 shares under ATM program in Q2
2025-07-03 19:55C:NGEN3.49News ReleaseNervgen Pharma director Ives resigns
2025-07-01 07:31C:NGEN3.44News ReleaseNervGen Announces Clinical Leadership Transition as NVG-291 Continues to Advance Toward Late-Stage Development and Regulatory Milestones
2025-06-18 16:40C:NGEN3.58News ReleaseNervgen appoints Kaye as chief medical adviser
2025-06-02 16:48C:NGEN3.55News ReleaseNervgen finds NVG-291 meets only 1 co-primary end point
2025-06-02 10:22C:NGEN5.15Resume TradingNervgen Pharma to resume at 7:24 a.m. PT
2025-06-02 10:21C:NGEN5.15Halt TradingNervgen Pharma halted at 7:19 a.m. PT
2025-06-02 10:18C:NGEN5.15Resume TradingNervgen Pharma resumes at 7:15 a.m. PT
2025-06-02 10:17C:NGEN5.15Halt TradingNervgen Pharma halted at 7:10 a.m. PT
2025-06-02 09:55C:NGEN5.15News ReleaseCanadian Investment Regulatory Organization Trade Resumption - NGEN
2025-06-02 09:52C:NGEN5.15News ReleaseCanadian Investment Regulatory Organization Trading Halt - NGEN
2025-06-02 09:40C:NGEN5.15Resume TradingNervgen Pharma to resume at 6:43 a.m. PT
2025-06-02 09:39C:NGEN5.15Halt TradingNervgen Pharma halted at 6:38 a.m. PT
2025-05-23 10:32C:NGEN5.40News ReleaseCanadian Investment Regulatory Organization Trade Resumption - NGEN
2025-05-23 10:28C:NGEN5.40News ReleaseCanadian Investment Regulatory Organization Trading Halt - NGEN
2025-05-23 10:16C:NGEN5.40Resume TradingNervgen Pharma to resume at 7:18 a.m. PT
2025-05-23 10:15C:NGEN5.40Halt TradingNervgen Pharma halted at 7:13 a.m. PT
2025-05-21 22:37C:NGEN6.57News ReleaseNervgen Pharma to present NVG-291 study data
2025-05-16 18:33C:NGEN4.68News ReleaseNervgen Pharma grants options to buy 600,000 shares